Welcome to LookChem.com Sign In|Join Free
  • or
3',6'-(Dimethylamino)-3-oxo-spiro[isobenzofuran-1(3H),9'-[9H]xanthene]-ar-carboxylic acid, commonly referred to as DMASPIC, is a synthetic organic compound characterized by its xanthene derivative structure and a unique spiro-cyclic configuration. 3',6'-(Dimethylamino)-3-oxo-spiro[isobenzofuran-1(3H),9'-[9H]xanthene]-ar-carboxylic acid features a dimethylamino group, which contributes to its potential antineoplastic and antitumor properties. DMASPIC has garnered interest in the field of oncology due to its demonstrated ability to inhibit cancer cell proliferation, induce apoptosis, and disrupt cell cycle regulation, positioning it as a promising candidate for cancer therapy development.

150347-56-1

Post Buying Request

150347-56-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

150347-56-1 Usage

Uses

Used in Oncology Research and Development:
DMASPIC is utilized as a potential cancer therapeutic agent for its capacity to suppress the growth of cancer cells. It is particularly noteworthy for its ability to induce apoptosis and interfere with the cell cycle, which are critical processes in the progression of cancer.
Used in Preclinical Cancer Studies:
In the realm of preclinical research, DMASPIC serves as a subject of investigation for its potential as an antineoplastic agent. 3',6'-(Dimethylamino)-3-oxo-spiro[isobenzofuran-1(3H),9'-[9H]xanthene]-ar-carboxylic acid's effects on cancer cells have shown promising results, warranting further exploration into its efficacy and safety as a cancer treatment.
Used in Drug Development for Cancer Treatment:
DMASPIC is considered in the development of new drugs aimed at treating cancer due to its demonstrated antitumor activities. Its unique structure and mechanism of action offer a novel approach to combating cancer, and ongoing research is focused on optimizing its potential for clinical use.
Used in Pharmaceutical Industry:
Within the pharmaceutical industry, DMASPIC is explored for its potential incorporation into new drug formulations designed to target various types of cancer. Its properties as a xanthene derivative with a spiro-cyclic structure and a dimethylamino group make it a compound of interest for the development of innovative cancer therapies.

Check Digit Verification of cas no

The CAS Registry Mumber 150347-56-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,0,3,4 and 7 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 150347-56:
(8*1)+(7*5)+(6*0)+(5*3)+(4*4)+(3*7)+(2*5)+(1*6)=111
111 % 10 = 1
So 150347-56-1 is a valid CAS Registry Number.

150347-56-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 5(6)-Carboxytetramethylrhodamine

1.2 Other means of identification

Product number -
Other names 3',6'-(DiMethylaMino)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:150347-56-1 SDS

150347-56-1Upstream product

150347-56-1Downstream Products

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 150347-56-1